<DOC>
	<DOC>NCT01353508</DOC>
	<brief_summary>Assess mechanism of action of LCZ696 related to sodium excretion.</brief_summary>
	<brief_title>Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>LCZ 696</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Patients with heart failure: documented NYHA class IIIII heart failure Patients with hypertension: stable hypertensive medication for the preceding 2 months Women of childbearing potential History of recent myocardial infarction History of dialysis or renal transplant Patients with type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Sodium excretion,</keyword>
	<keyword>LCZ696</keyword>
</DOC>